Bupropion SR Reduces Periodic Limb Movements Associated With Arousals From Sleep in Depressed Patients With Periodic Limb Movement Disorder

Eric A. Nofzinger, Amy Fasiczka, Susan Berman, and Michael E. Thase

Published: October 31, 2000

Article Abstract

Background: Antidepressant-inducedperiodic limb movement disorder (PLMD) may limit the tolerabilityof some antidepressant medications and interfere with treatmentresponse. Given the role of dopamine in PLMD and the effects ofbupropion sustained-release (SR) on central dopaminergicfunction, we hypothesized that bupropion SR would not beassociated with antidepressant-induced PLMD.

Method: In an expanded case-seriesdesign, we compared the effects of bupropion SR, after about 10weeks of treatment, on measures of PLMD, depression, and sleep in5 depressed (Research Diagnostic Criteria) patients who also metcriteria for having pretreatment PLMD. Depression was measuredusing the Beck Depression Inventory and the Hamilton Rating Scalefor Depression. Patients were considered to have PLMD ifpolysomnographic recordings showed > 5 periodic limbmovements/hour of sleep that were associated with arousals fromsleep.

Results: Bupropion SR treatment wasassociated with a reduction in measures of PLMD and animprovement in depression.

Conclusion: These results show thatbupropion SR is not associated with antidepressant-induced PLMD.Rather, bupropion SR treatment reduces objective measures of PLMDin depressed patients with the disorder.

Volume: 61

Quick Links: Restless Legs Syndrome , Sleep-Wake

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...